NATH BIO-GENES (INDIA) LTD.

NSE : NATHBIOGENBSE : 537291ISIN CODE : INE448G01010Industry : AgricultureHouse : Private
BSE199.550.65 (+0.33 %)
PREV CLOSE ( ) 198.90
OPEN PRICE ( ) 201.00
BID PRICE (QTY) 200.00 (50)
OFFER PRICE (QTY) 200.80 (1)
VOLUME 823
TODAY'S LOW / HIGH ( )199.35 201.20
52 WK LOW / HIGH ( )155.1 243.7
NSE199.900.85 (+0.43 %)
PREV CLOSE( ) 199.05
OPEN PRICE ( ) 200.10
BID PRICE (QTY) 200.10 (3)
OFFER PRICE (QTY) 200.55 (4)
VOLUME 18509
TODAY'S LOW / HIGH( ) 198.50 202.20
52 WK LOW / HIGH ( )156.85 244.6

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.